Grown Rogue International (GRUSF) EBT Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 48.64% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -393.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -24.84% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.01% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,578.91% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 45.00% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -223.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -223.46% |
| Dec 31, 2025 | -152.69% |
| Sep 30, 2025 | 813.09% |
| Jun 30, 2025 | 132.55% |
| Mar 31, 2025 | 136.21% |
| Dec 31, 2024 | 1,669,307,656.58% |
| Jan 31, 2023 | 246.72% |
| Jan 31, 2022 | 119.33% |
| Oct 31, 2021 | 145.55% |
| Jul 31, 2021 | -3.59% |
| Apr 30, 2021 | -11.43% |
| Jan 31, 2021 | -269.96% |
| Oct 31, 2020 | -297.82% |
| Jul 31, 2020 | 197.74% |
| Apr 30, 2020 | 68.48% |
| Jan 31, 2020 | 94.01% |
| Oct 31, 2019 | 41.47% |
| Jul 31, 2019 | -286.50% |
| Apr 30, 2019 | -184.47% |
| Jan 31, 2019 | -588.22% |